Peetz Christopher
- SEC CIK
- 0001614740
In the past year, 9 open-market sale filings worth $18.1M and no purchases.
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $18.1M
- 9 filings
- Net
- −$18.1M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Peetz Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MIRM Mirum Pharmaceuticals, Inc.
CHIEF EXECUTIVE OFFICER22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 (view filing)8:46 PM ET | Nov 4 | Same day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −20.0K | $90.00 | −$1.80M | −8.8%206.6K after | 10b5-1 |
| Sep 3, 2026 (view filing)6:52 PM ET | Sep 1 | 2 days | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −30.0K | $98.68 | −$2.96M | −13.4%194.4K after | 2 lots10b5-1 |
| Aug 11, 2026 (view filing)5:41 PM ET | Aug 10 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −20.0K | $98.92 | −$1.98M | −9.3%194.3K after | 3 lots10b5-1 |
| Jul 8, 2026 (view filing)5:12 PM ET | Jul 6 | 2 days | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −20.0K | $122.27 | −$2.45M | −9.3%194.3K after | 4 lots10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −30.0K | $95.84 | −$2.88M | −13.4%194.3K after | 6 lots10b5-1 |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −41.0K | $91.98 | −$3.77M | −17.4%194.3K after | |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −9.11K | $103.30 | −$940.9K | −5.4%160.3K after | |
| Jan 27, 2026 (view filing) | Jan 26 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −6.83K | $96.19 | −$657.1K | −3.9%169.4K after | |
| Jan 23, 2026 (view filing) | Jan 22 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −7.10K | $93.33 | −$662.5K | −4.2%163.7K after | |
| Aug 12, 2025 (view filing) | Aug 11 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −40.0K | $62.00 | −$2.48M | −22.4%138.6K after | 10b5-1 |
ALPN Alpine Immune Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2021 (view filing) | Sep 23 | 4 days | Peetz ChristopherDirector | PPurchase | +1.90K | $10.17 | +$19.3K | New position1.90K after | Amended |